Shanghai RAAS Blood Products Co., Ltd. 002252

Overview

Shanghai RAAS Blood Products Co., Ltd. is a prominent company based in Shanghai, China, specializing in the development, manufacturing, and sale of various blood products. Established in 1988, the company has grown to become one of China's leading suppliers in the blood product industry. Through its extensive research and development efforts, Shanghai RAAS has been able to offer a wide range of critical blood-derived products that are essential in the medical treatment of various diseases and conditions.

Products and Services

Shanghai RAAS Blood Products Co., Ltd. provides an expansive portfolio of blood products, catering to different medical needs. These include:

• Human Serum Albumin: Utilized commonly in the treatment of shock, burns, and other conditions requiring plasma volume replacement.
• Human Intravenous Immunoglobulin: Offers vital immune support for individuals with immune deficiencies and is used in the treatment of various autoimmune and inflammatory diseases.
• Human Coagulation Factor VIII: Essential for the management and treatment of hemophilia A, a genetic disorder impairing blood coagulation.
• Human Prothrombin Complex: Used in the management of bleeding disorders, especially for patients with deficiencies in clotting factors.
• Human Fibrinogen: A critical factor in blood clot formation, used in the treatment of congenital and acquired fibrinogen deficiency.
• Human Thrombin and Human Fibrin Adhesive: These products are used in surgeries as hemostatic agents to control bleeding.
• Human Immunoglobulin: Plays a role in boosting the immune system, especially for patients with weakened immune systems.
• Hepatitis B Immunoglobulin: Provides passive immunity to hepatitis B, used particularly after exposure to the virus or for newborns of infected mothers.
• Tetanus Immunoglobulin: Offers passive immunization against tetanus in cases of wounds likely to be contaminated with Clostridium tetani.
• Rabies Immunoglobulin: Provides immediate protection against the rabies virus following exposure before the vaccine starts to take effect.